MCK
NYSE McKesson Corporation$902.28 ↑ +0.00 (+0.00%) Trading Up from the previous close of $902.28, $3.27 below the day’s high of $905.55
- YTD change
- +10.00%
- vs 20-day SMA
- +2.00%
- vs 200-day SMA
- +6.52%
Price ranges
Price & Performance
+45.51 (+5.31%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 9.7% away from all-time highs of $999.00
- MCK is up 10% since the beginning of the year
- MCK is up 19% over the past 12 months
- MCK is down 2% over the past 1 month
- 2% of all MCK investors are betting against MCK
- Number of investors short MCK has gone up 2% versus last month
MCK reads very good: price sits above both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +22.3%.
- Previous minute
- +$0.00
- Last hour
- -$14.73
- Last 5 days
- +3.79%
- vs 8-day SMA
- +3.39%
No alerts for MCK in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. The North American Pharmaceutical segment focuses on distribution of branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs to customers in U.S. and Canada. The Oncology and Multispecialty segment includes provision of solutions that includes specialty drug distribution, group purchasing organizations, infusion services, direct to patient pharmacy capabilities, InspiroGene cell and gene therapy services, technology solutions, practice consulting services, and vaccine distribution. The RxTS segment focuses on solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
